Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease

被引:11
|
作者
Wu, Weiti [1 ]
Xiang, Jingjing [2 ]
Chen, Xiaoye [3 ]
机构
[1] Taizhou Hosp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China
[2] Taizhou Hosp, Dept Emergency, Taizhou, Zhejiang, Peoples R China
[3] Taizhou Hosp, Dept Radiotherapy, Taizhou, Zhejiang, Peoples R China
来源
关键词
non-alcoholic fatty liver disease; diabetes mellitus; NHANES; cardiovascular; mortality; HEPATIC INSULIN-RESISTANCE; NAFLD; RISK; PATHOGENESIS; MEN;
D O I
10.3389/fendo.2021.773342
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThe influence of diabetes on mortality among patients with non-alcoholic fatty liver disease (NAFLD) in the general population has not been extensively studied. This study aimed to determine the relationship between diabetes and all-cause and cardiovascular mortality in patients with hepatic ultrasound-confirmed NAFLD using data from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. MethodsData from 4,037 adult individuals with NAFLD from the NHANES III and mortality outcomes linked to National Death Index records through December 31, 2015, were included. Cox proportional hazards models were used to calculate the hazard ratio (HR) and corresponding 95% CI for mortality from all causes and cardiovascular disease after adjusting for multiple variables. ResultsAmong 4,037 subjects with NAFLD (55.9% female), 483 had diabetes at baseline. During a median follow-up of 22.1 years, 1,517 (11.5%) died, including 332 (8.22%) from cardiovascular causes. Diabetes was associated with increased all-cause (HR 3.02 [95% CI 2.67-3.41]) and cardiovascular (HR 3.36 [95% CI 2.61-4.32]) mortality in an unadjusted multivariable Cox regression model. The association remained statistically significant after adjusting for a range of potential confounders (HR 2.20 [95% CI 1.90-2.55] for all-cause mortality and HR 2.47 [95% CI 1.81-3.37] for cardiovascular mortality). An additional stratified analysis did not reveal significantly altered results. ConclusionDiabetes was associated with all-cause and cardiovascular mortality in patients with NAFLD. This link could be further characterized in future studies assessing the degree of glycemic control and its relationship with mortality in patients with diabetes and NAFLD.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Association between Lifestyle Modification and All-Cause, Cardiovascular, and Premature Mortality in Individuals with Non-Alcoholic Fatty Liver Disease
    Huang, Yanqiu
    Xu, Jinfan
    Yang, Yang
    Wan, Tingya
    Wang, Hui
    Li, Xiaoguang
    NUTRIENTS, 2024, 16 (13)
  • [2] Metabolic score for visceral fat is correlated with all-cause and cardiovascular mortality among individuals with non-alcoholic fatty liver disease
    Chunming Xie
    Xianpei Chen
    Jiakun Zhang
    Xueqing Jiang
    Jing Xu
    Hao Lin
    BMC Gastroenterology, 25 (1)
  • [3] Association between body roundness index and risk of ultrasound-defined non-alcoholic fatty liver disease
    Zhao, Enfa
    Wen, Xiaolin
    Qiu, Wenqian
    Zhang, Chaoxue
    HELIYON, 2024, 10 (01)
  • [4] Association between prognostic nutritional index and all-cause mortality and cardiovascular disease mortality in American adults with non-alcoholic fatty liver disease
    Lei, Yuqing
    Tao, Shaohong
    Yang, Yubo
    Xie, Fang
    Xie, Weining
    FRONTIERS IN NUTRITION, 2025, 12
  • [5] Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
    Ng, Cheng Han
    Wong, Zhen Yu
    Chew, Nicholas W. S.
    Chan, Kai En
    Xiao, Jieling
    Sayed, Nilofer
    Lim, Wen Hui
    Tan, Darren Jun Hao
    Loke, Ryan Wai Keong
    Tay, Phoebe Wen Lin
    Yong, Jie Ning
    Kong, Gywneth
    Huang, Daniel Q.
    Wang, Jiong-Wei
    Chan, Mark
    Dalakoti, Mayank
    Tamaki, Nobuharu
    Noureddin, Mazen
    Siddiqui, Mohammad Shadab
    Sanyal, Arun J.
    Muthiah, Mark
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [6] AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), STATINS DO NOT REDUCE CARDIOVASCULAR OR ALL-CAUSE MORTALITY
    Golabi, Pegah
    Paik, James
    Bush, Haley
    Cable, Rebecca
    Racila, Andrei
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2018, 154 (06) : S950 - S950
  • [7] Non-alcoholic fatty liver disease and all-cause and cardiovascular mortality: a population based cohort study
    Mahady, S.
    Wong, G.
    Turner, R.
    Craig, J.
    George, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 93 - 93
  • [8] Association of serum C-peptide with all- cause and cardiovascular disease mortality in ultrasound-defined nonalcoholic fatty liver disease
    Zhao, Enfa
    Chen, Shimin
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (10)
  • [9] Association of Triglyceride Glucose-Related Parameters with All-cause mortality and Cardiovascular Disease in Non-alcoholic Fatty Liver Disease Patients
    Chen, Yaqin
    Zhang, Yusha
    Wang, Fengjiao
    CIRCULATION, 2024, 150
  • [10] THE PREVALENCE AND EFFECTS ON ALL-CAUSE AND CARDIOVASCULAR MORTALITY OF TREATED AND UNTREATED HYPERTENSION IN NON-ALCOHOLIC FATTY LIVER DISEASE
    Tang, Ansel Shao Pin
    Wong, Zhen Yu
    Ng, Cheng Han
    Chew, Nicholas Ws
    Lim, Wen Hui
    Tan, Darren Jun Hao
    Chan, Kai En
    Siddiqui, Mohammad Shadab
    Noureddin, Mazen
    Sanyal, Arun J.
    Muthiah, Mark Dhinesh
    HEPATOLOGY, 2022, 76 : S677 - S678